Skip to main content

October 2021

 

 

academics

 

Clinical research courses

Olema Oncology Announces Trials in Progress Poster on OP-1250 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc.

BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in Phase 2 Trial of mRNA-based Individualized Immunotherapy BNT122 in Colorectal Cancer Patients

MAINZ, GERMANY, October 1, 2021 (GLOBE NEWSWIRE) – BioNTech SE announced that the first colorectal cancer patient has been treated with its individualized mRNA cancer vaccine BNT122 (autogene cevumeran, RO7198457) in a Phase 2 clinical trial. The trial has been initiated in the United States, Germany, Spain and Belgium. It is planned to enroll about 200 patients to evaluate the efficacy of RO7198457 (BNT122) compared to watchful waiting after surgery and chemotherapy, the current standard of care for these high-risk patients.

Gujarat State Pharmacy Council to offer financial assistance to family of pharmacist who died in Corona pandemic

​Gujarat State Pharmacy Council (GSPC) had organised celebration of World Pharmacist Day on 25th Sept 2021 in which more than 300 pharmacists from the pharmacy sector of the state of Gujarat were present. In this event GSPC announced financial assistance to the family of a Gujarat pharmacist who died while on duty in Corona pandemic.